VFA
TTOO

Valeo Financial Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Valeo Financial Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$4K – 617
2022
Q3 		$4K Hold
7
– – ﹤0.01% 505
2022
Q2 		$6K Hold
7
– – ﹤0.01% 509
2022
Q1 		$18K Hold
7
– – ﹤0.01% 627
2021
Q4 		$18K Hold
7
– – ﹤0.01% 585
2021
Q3 		$32K Buy
7
+4
+133% +$20.1K ﹤0.01% 564
2021
Q2 		$21K Hold
3
– – ﹤0.01% 506
2021
Q1 		$28K Buy
+3
New +$31.8K ﹤0.01% 1058

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Valeo Financial Advisors's TTOO Position: Q4 2022 in Review

Valeo Financial Advisors sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 7 shares — an estimated $4K sold.

Valeo Financial Advisors first reported a position in TTOO in Q1 2021 and held it in 7 quarters. The position peaked at $32K in Q3 2021. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Valeo Financial Advisors reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Valeo Financial Advisors sold 7 T2 Biosystems, Inc shares in Q4 2022, an estimated $4K.
  • Valeo Financial Advisors first reported a position in T2 Biosystems, Inc in Q1 2021 and held it in 7 quarters.
  • Valeo Financial Advisors's T2 Biosystems, Inc position peaked at $32K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Valeo Financial Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.